QIAGEN Digital Insights Thursday, July 7, 2016

A recent report on HGMD shows how customers rate the database of human genome mutations. Partnering with the research firm TechValidate, we...

QIAGEN Digital Insights Tuesday, June 7, 2016

The European Association for Cancer Research is hosting EACR24 in Manchester, UK on July 9-12, 2016.  We're looking forward to...

QIAGEN Digital Insights Monday, May 30, 2016

We often think of rare diseases as being rare, affecting only a small number of people. When looked at from...

QIAGEN Digital Insights Thursday, May 12, 2016

Human Genome Variation Society (HGVS) is hosting a meeting on "Clinical Interpretation of Variants from Next-Generation Sequencing". The meeting will...

QIAGEN Digital Insights Monday, April 25, 2016

It’s DNA Day! DNA Day marks two significant DNA-related milestones — the 1953 discovery of DNA’s double helix and the...

QIAGEN Digital Insights Thursday, April 21, 2016

Part four of our webinar series on liquid biopsies:Circulating cell-free DNA purification, sequencing and data interpretation Identification and monitoring of cancer...

QIAGEN Digital Insights Tuesday, April 19, 2016

Our hereditary disease solution performs best in terms of clinical accuracy at the Critical Assessment of Genome Interpretation (CAGI) conference....

QIAGEN Digital Insights Thursday, April 14, 2016

New, powerful bioinformatics tool: The RNA-Seq Explorer Solution Today we announced our new RNA-Seq Explorer Solution — a powerful bioinformatics...

QIAGEN Digital Insights Thursday, April 14, 2016

From IPA and Ingenuity® Variant Analysis™ to Biomedical Genomics Workbench, we’re honored to see that our products are on the...

QIAGEN Digital Insights Tuesday, April 12, 2016

Circulating tumor cells (CTCs) are tumor cells circulating freely in the peripheral blood of patients. The characterization of CTCs is...

Sample to Insight
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.